Last NEWS
I2MC
1rst RDV Pizza-techno september 20th at 12h30
Séminaire interne – Imagerie et ANEXPLO – 13 septembre 11h
Webinar – Pr. Andrew E. GELMAN september 21th 16h
Teams link : https://teams.microsoft.com/l/meetup-join/19%3ameeting_NGJkYWYxMDktNzMwZS00ZDZjLTkxMmMtNDBlNDlmZDM3NjU4%40thread.v2/0?context=%7b%22Tid%22%3a%2299dde8fb-92f6-414d-bc5e-44ffa3e2419c%22%2c%22Oid%22%3a%22d5598274-39b1-4fc1-9ac7-e7beaa698dfd%22%7d openagenda...
EndoTreat: research project conducted in partnership with the Toulouse University Hospital (E. Chantalat), INSERM-I2MC (F. Lenfant) and the start-up company Urosphère
Endometriosis: researchers in Toulouse study the disease by creating organoids (Equipe de Françoise LENFANT) Click here to read article in the Dépêche. To better understand the mechanisms of endometriosis, an oestrogen-dependent disease that affects 10% of women in...
We-Met involved in Europen project HERVCOV
The protein that opens doors to the medicine of the future and treatment of COVID-19 “Understand the pathogenic role of HERV-W envelope protein and develop novel prognostic markers and therapeutic targets for personalized treatment of COVID-19-associated...
New review from LIPSIPLAT (B. Payrastre) team in ATVB
PIKfyve-dependent phosphoinositide dynamics in megakaryocyte/platelet granule integrity and platelet functions Auteurs : Manuella Caux, Rana Mansour, Jean-Marie Xuereb, Gaëtan Chicanne, Julien Viaud1, Alicia Vauclard, Frédéric Boal, Bernard Payrastre, Hélène...
Garmy-Susini/Prats team obtains FRM-Equipe label
L’équipe « Régulations moléculaires des facteurs (lymph)angiogéniques dans les pathologies vasculaires » dirigée par Barbara Garmy-Susini et Anne-Catherine Prats vient d’obtenir la labélisation FRM-Equipe pour ses travaux portant sur l’étude des ARN non codants dans...
New review from LiMitAging (L. MARTINEZ) in the International Journal of Molecular Sciences
The Interplay of Endothelial P2Y Receptors in Cardiovascular Health: From Vascular Physiology to Pathology Auteurs : Cendrine CABOU et Laurent MARTINEZ Int J Mol Sci. 2022 May 24;23(11):5883. doi: 10.3390/ijms23115883. PMID: 35682562; PMCID: PMC9180512. Abstract The...
Discovery and quantification of lipoamino acids in bacteria – Lipidomic facility
Improving knowledge about metabolites produced by the microbiota is a key point to understand its role in human health and disease. Among them, lipoamino acid (LpAA) containing asparagine and their derivatives are bacterial metabolites which could have an impact on...
A new mass spectrometer high resolution on Metatoul-Lipidomic facility: EXPLORIS 240
Thanks to CPER and regional funding (Occitanie Octopus project), the MetaToul-Lipidomic platform has acquired a chromatography instrument coupled to a high-resolution mass spectrometer of the Exporis 240 (Thermo). This instrument, which replaces our simple Exactive,...
Inserm/UPS UMR 1297 - I2MC Institut des Maladies Métaboliques et Cardiovasculaires
1 avenue Jean Poulhès - BP 84225 - 31432 Toulouse Cedex 4
Tél. : 05 61 32 56 00
Horaires
Du lundi au vendredi
8h30 - 12h30 / 13h45 -16h45
